ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
-17.58%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$221M
AUM Growth
-$91.2M
(-29%)
Cap. Flow
-$29.6M
Cap. Flow
% of AUM
-13.42%
Top 10 Holdings %
Top 10 Hldgs %
60.19%
Holding
73
New
20
Increased
14
Reduced
17
Closed
20
Top Buys
| 1 |
Sanofi
SNY
|
$17.9M |
| 2 |
Pfizer
PFE
|
$16.7M |
| 3 |
Hologic
HOLX
|
$16.6M |
| 4 |
SI-BONE Inc
SIBN
|
$10.2M |
| 5 |
Johnson & Johnson
JNJ
|
$6.36M |
Top Sells
| 1 |
Cencora
COR
|
$18.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
$14.7M |
| 3 |
Labcorp
LH
|
$10.3M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$10.3M |
| 5 |
Elevance Health
ELV
|
$8.78M |
Sector Composition
| 1 | Healthcare | 89.6% |
| 2 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Centene
CNC
$14.1B
| $2.27M | 1.03% |
+38,196
| New | +$2.27M |
|
27
DaVita
DVA
$9.69B
| $2.07M | 0.94% |
27,164
+15,162
| +126% | +$1.15M |
|
28
Dentsply Sirona
XRAY
$2.86B
| $2.04M | 0.93% |
52,645
-4,080
| -7% | -$158K |
|
|
TRIL
29
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.93M | 0.87% |
+477,704
| New | +$1.93M |
|
30
Charles River Laboratories
CRL
$7.99B
| $1.66M | 0.75% |
+13,147
| New | +$1.66M |
|
|
GWPH
31
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.48M | 0.67% |
16,890
-12,820
| -43% | -$1.12M |
|
|
ZGNX
32
DELISTED
Zogenix, Inc.
ZGNX
| $1.45M | 0.66% |
+58,787
| New | +$1.45M |
|
33
Insmed
INSM
$30.1B
| $1.19M | 0.54% |
+74,365
| New | +$1.19M |
|
34
AtriCure
ATRC
$1.77B
| $1.12M | 0.51% |
+33,453
| New | +$1.12M |
|
35
Fate Therapeutics
FATE
$112M
| $905K | 0.41% |
40,732
-94,290
| -70% | -$2.09M |
|
36
IQVIA
IQV
$31.3B
| $899K | 0.41% |
8,332
-41,449
| -83% | -$4.47M |
|
37
Axsome Therapeutics
AXSM
$6.21B
| $728K | 0.33% |
12,367
+1,216
| +11% | +$71.6K |
|
|
AVDL
38
Avadel Pharmaceuticals
AVDL
$1.46B
| $696K | 0.32% |
+87,676
| New | +$696K |
|
39
Cartesian Therapeutics
RNAC
$260M
| $615K | 0.28% |
8,510
+7,650
| +890% | +$553K |
|
40
Iovance Biotherapeutics
IOVA
$796M
| $605K | 0.27% |
20,207
-148,339
| -88% | -$4.44M |
|
41
Standard BioTools
LAB
$493M
| $590K | 0.27% |
232,291
-802,342
| -78% | -$2.04M |
|
|
PRNB
42
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $530K | 0.24% |
8,927
-57,230
| -87% | -$3.4M |
|
43
MacroGenics
MGNX
$123M
| $510K | 0.23% |
87,703
-35,197
| -29% | -$205K |
|
44
HCA Healthcare
HCA
$96.3B
| $509K | 0.23% |
+5,666
| New | +$509K |
|
|
GNCA
45
DELISTED
Genocea Biosciences, Inc.
GNCA
| $455K | 0.21% |
264,307
+26,100
| +11% | +$44.9K |
|
|
ADAP
46
Adaptimmune Therapeutics
ADAP
$13.5M
| $435K | 0.2% |
+159,826
| New | +$435K |
|
47
Ovid Therapeutics
OVID
$91.7M
| $347K | 0.16% |
+116,297
| New | +$347K |
|
48
PetMed Express
PETS
$62.8M
| $287K | 0.13% |
+9,964
| New | +$287K |
|
|
KDMN
49
DELISTED
Kadmon Holdings, Inc.
KDMN
| $256K | 0.12% |
+61,188
| New | +$256K |
|
50
AbbVie
ABBV
$376B
| – | – |
-98,596
| Closed | -$8.73M |
|